US Healthcare Advertising Market Report & Forecast: 2016-2021
Health related issues are growing rapidly all over the world making healthcare a major issue of concern. Health problems are fuelled by poverty, aging population and obesity in both developed and developing societies. As the economies grow and global disposable incomes rise, individuals demand better care and advanced medical interventions. Thus, the pace of growth in global health care spending, particularly in developing nations, is expected to accelerate rapidly for the foreseeable future. The healthcare spending in the United States is far greater than other countries. Currently, the United States has one of the highest per capita expenditure on healthcare with estimates suggesting that by 2020 the US will spend approximately 28% of its GDP on healthcare.
The increasing value that people place on social media and advertisements has brought about the integration of marketing and healthcare in the recent past. Healthcare corporations are increasing their expenditure on advertising through various channels like, television, print ads, social media, detailing, etc. and there is a shift of healthcare brands putting more money into the digital space.
The key healthcare segments analysed in this report are the Pharmaceutical (small molecule drugs) Market, Biopharmaceutical Market, Vaccines Market and Over-the-Counter (OTC) Drugs Market in the United States. For each of the healthcare segments, the report provides the share of various advertising channels such as detailing, sampling, Direct-to-Consumer (DTC), mailing/e-mailing, print advertising, etc. The report finds that detailing represents the most preferred mode of promotion across all the healthcare segments.
The healthcare market in the United States comprises of major players like Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline and Roche, among many others. All these pharmaceutical corporations spend a large amount of their earnings on promotions and advertising of their drugs and healthcare products.
IMARC’s new report “US Healthcare Advertising Market Report & Forecast: 2016-2021” provides an analytical and statistical insight into the advertising trends in the healthcare sector in the United States. The market analysis includes market trends, key players in the healthcare sector, sales and advertising trends in the different sectors, breakup by advertising channels, etc. The study, which is based both on desk research and multiple waves of qualitative primary research, is a must-read for entrepreneurs, investors, researchers, consultants, business strategists and all those who are planning to foray into US healthcare advertising market in any manner.
Key Questions Answered in this Report:
The increasing value that people place on social media and advertisements has brought about the integration of marketing and healthcare in the recent past. Healthcare corporations are increasing their expenditure on advertising through various channels like, television, print ads, social media, detailing, etc. and there is a shift of healthcare brands putting more money into the digital space.
The key healthcare segments analysed in this report are the Pharmaceutical (small molecule drugs) Market, Biopharmaceutical Market, Vaccines Market and Over-the-Counter (OTC) Drugs Market in the United States. For each of the healthcare segments, the report provides the share of various advertising channels such as detailing, sampling, Direct-to-Consumer (DTC), mailing/e-mailing, print advertising, etc. The report finds that detailing represents the most preferred mode of promotion across all the healthcare segments.
The healthcare market in the United States comprises of major players like Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline and Roche, among many others. All these pharmaceutical corporations spend a large amount of their earnings on promotions and advertising of their drugs and healthcare products.
IMARC’s new report “US Healthcare Advertising Market Report & Forecast: 2016-2021” provides an analytical and statistical insight into the advertising trends in the healthcare sector in the United States. The market analysis includes market trends, key players in the healthcare sector, sales and advertising trends in the different sectors, breakup by advertising channels, etc. The study, which is based both on desk research and multiple waves of qualitative primary research, is a must-read for entrepreneurs, investors, researchers, consultants, business strategists and all those who are planning to foray into US healthcare advertising market in any manner.
Key Questions Answered in this Report:
- How is healthcare advertising different from conventional advertising?
- What are the different channels for healthcare advertising?
- What drives the healthcare advertising market in the US?
- What is the value chain of the healthcare advertising market in the US?
- What are the current trends in the healthcare advertising sector?
- What are the historical, current and future trends of the advertising spend on healthcare sector in the US?
- What are the historical, current and future sales value trends and advertising spend of the pharmaceutical (small molecule drugs) market in the healthcare sector in the US?
- What are the historical, current and future sales value trends and advertising spend of the biopharmaceutical market in the US?
- What are the historical, current and future sales value trends and advertising spend of the vaccines market in the US?
- What are the historical, current and future sales value trends and advertising spend of the Over-the-Counter (OTC) drugs market in the US?
- What is the breakup of the key advertising channels of the pharmaceutical market in the US?
- What is the breakup of the key advertising channels of the biopharmaceutical market in the US?
- What is the breakup of the key advertising channels of the vaccines market in the US?
- What is the breakup of the key advertising channels of the Over-the-Counter (OTC) drugs market in the US?
- Who are the key players in the pharmaceutical market, biopharmaceutical market, vaccines market and Over-the-Counter (OTC) drugs market in the US and what is their advertising spend?
- Who are the key players in the US healthcare advertising market and what are the trends of their sales and advertising spend?
- What are the challenges of the healthcare advertising market in the US?
1 RESEARCH METHODOLOGY AND MARKET DEFINITIONS
2 EXECUTIVE SUMMARY
3 AN OVERVIEW OF HEALTHCARE ADVERTISING IN THE UNITED STATES
4 WHAT DRIVES THE HEALTHCARE ADVERTISING MARKET IN THE UNITED STATES?
4.1 Digitalization and other Technological Advancements
4.2 Increasing Presence of Generic and Me-too Drugs
4.3 Government Regulations Supporting DTC Advertising
4.4 Launch of New Drugs
4.5 Increased Consumer Reach through Mobile Advertising
4.6 Other Key Drivers
5 HEALTHCARE ADVERTISING MARKET: VALUE CHAIN
5.1 DTC Advertising
5.2 Detailing
6 CURRENT TRENDS IN HEALTHCARE ADVERTISING
6.1 Focus on Content
6.2 Rise of Multichannel Marketing
6.3 Targeting Consumers with Local Advertising
6.4 Reliance on Social Media
6.5 Surging Mobile Marketing
6.6 Consumers Becoming Researchers
6.7 Information Dispensed through Videos
6.8 Increasing Importance of Online Reviews
7 US HEALTHCARE ADVERTISING MARKET
7.1 Historical and Current Market Trends
7.2 Market Segmentation by Product Type
7.2.1 Pharmaceutical (Small Molecule Drugs) Advertising Market
7.2.1.1 Historical, Current and Future Trends in the Pharmaceutical (Small Molecule Drugs) Market
7.2.1.2 Historical, Current and Future Trends in the Pharmaceutical (Small Molecule) Advertising Market
7.2.1.3 Market Breakup by Advertising Channel
7.2.1.4 Advertising Spend by Key Players
7.2.2 Biopharmaceutical Market
7.2.2.1 Historical, Current and Future Market Trends in the Biopharmaceutical Market
7.2.2.2 Historical, Current and Future Market Trends in the Biopharmaceutical Advertising Market
7.2.2.3 Market Breakup by Advertising Channel
7.2.2.4 Advertising spend by Key Players
7.2.3 Vaccines Market
7.2.3.1 Historical, Current and Future Market Trends in the Vaccines Market
7.2.3.2 Historical, Current and Future Market Trends in the Vaccines Advertising Market
7.2.3.3 Market Breakup by Advertising Channel
7.2.3.4 Advertising Spend by Key Players
7.2.1 Over-the-Counter Drugs Market
7.2.1.1 Historical, Current and Future Market Trends in the OTC Drugs Market
7.2.1.2 Historical, Current and Future Market Trends in the OTC Drugs Advertising Market
7.2.1.3 Market Breakup by Channel
7.2.1.4 Advertising Spend by Key Players
8 MAJOR PLAYERS: SALES AND ADVERTISING SPEND
8.1 Advertising Spend by Major Pharma Companies
8.1.1 Johnson & Johnson
8.1.1.1 US Sales
8.1.1.2 Advertising Spend by Channel
8.1.1.3 Global Sales and Advertising Spend
8.1.2 Pfizer
8.1.2.1 US Sales
8.1.2.2 Advertising Spend by Channel
8.1.2.3 Global Sales and Advertising Spend
8.1.3 Merck & Co.
8.1.3.1 US Sales
8.1.3.2 Advertising Spend by Channel
8.1.3.3 Global Sales and Advertising Spend
8.1.4 GlaxoSmithKline
8.1.4.1 US Sales
8.1.4.2 Advertising Spend By Channel
8.1.4.3 Global Sales and Advertising Spend
8.1.5 Eli Lilly
8.1.5.1 US Sales
8.1.5.2 Advertising Spend by Channel
8.1.5.3 Global Sales and Advertising Spend
8.1.6 Novartis
8.1.6.1 US Sales
8.1.6.2 Total Sales of Different Segments
8.1.6.3 Advertising Spend by Channel
8.1.6.4 Global Sales and Advertising Spend
8.1.7 Sanofi
8.1.7.1 US Sales
8.1.7.2 Advertising Spend on Different Segments
8.1.7.3 Global Sales and Advertising Spend
8.1.8 AstraZeneca
8.1.8.1 US Sales
8.1.8.2 Advertising Spend by Channel
8.1.8.3 Global Sales and Advertising Spend
8.1.9 Roche
8.1.9.1 US Sales
8.1.9.2 Advertising Spend on Different Segments
8.1.9.3 Global Sales and Advertising Spend
8.1.10 Bayer HealthCare
8.1.10.1 US Sales
8.1.10.2 Advertising Spend on Different Segments
8.1.10.3 Global Sales and Advertising Spend
8.1.11 Bristol- Myers Squibb
8.1.11.1 US Sales
8.1.11.2 Advertising Spend by Channel
8.1.11.3 Global Sales and Advertising Spend
9 MARKET CHALLENGES
9.1 Trust Gap between Consumers and Advertisers
9.2 Strict Rules and Regulations by FDA
9.3 Unethical Practices
9.4 Macroeconomic Scenario
9.5 Other Challenges
2 EXECUTIVE SUMMARY
3 AN OVERVIEW OF HEALTHCARE ADVERTISING IN THE UNITED STATES
4 WHAT DRIVES THE HEALTHCARE ADVERTISING MARKET IN THE UNITED STATES?
4.1 Digitalization and other Technological Advancements
4.2 Increasing Presence of Generic and Me-too Drugs
4.3 Government Regulations Supporting DTC Advertising
4.4 Launch of New Drugs
4.5 Increased Consumer Reach through Mobile Advertising
4.6 Other Key Drivers
5 HEALTHCARE ADVERTISING MARKET: VALUE CHAIN
5.1 DTC Advertising
5.2 Detailing
6 CURRENT TRENDS IN HEALTHCARE ADVERTISING
6.1 Focus on Content
6.2 Rise of Multichannel Marketing
6.3 Targeting Consumers with Local Advertising
6.4 Reliance on Social Media
6.5 Surging Mobile Marketing
6.6 Consumers Becoming Researchers
6.7 Information Dispensed through Videos
6.8 Increasing Importance of Online Reviews
7 US HEALTHCARE ADVERTISING MARKET
7.1 Historical and Current Market Trends
7.2 Market Segmentation by Product Type
7.2.1 Pharmaceutical (Small Molecule Drugs) Advertising Market
7.2.1.1 Historical, Current and Future Trends in the Pharmaceutical (Small Molecule Drugs) Market
7.2.1.2 Historical, Current and Future Trends in the Pharmaceutical (Small Molecule) Advertising Market
7.2.1.3 Market Breakup by Advertising Channel
7.2.1.4 Advertising Spend by Key Players
7.2.2 Biopharmaceutical Market
7.2.2.1 Historical, Current and Future Market Trends in the Biopharmaceutical Market
7.2.2.2 Historical, Current and Future Market Trends in the Biopharmaceutical Advertising Market
7.2.2.3 Market Breakup by Advertising Channel
7.2.2.4 Advertising spend by Key Players
7.2.3 Vaccines Market
7.2.3.1 Historical, Current and Future Market Trends in the Vaccines Market
7.2.3.2 Historical, Current and Future Market Trends in the Vaccines Advertising Market
7.2.3.3 Market Breakup by Advertising Channel
7.2.3.4 Advertising Spend by Key Players
7.2.1 Over-the-Counter Drugs Market
7.2.1.1 Historical, Current and Future Market Trends in the OTC Drugs Market
7.2.1.2 Historical, Current and Future Market Trends in the OTC Drugs Advertising Market
7.2.1.3 Market Breakup by Channel
7.2.1.4 Advertising Spend by Key Players
8 MAJOR PLAYERS: SALES AND ADVERTISING SPEND
8.1 Advertising Spend by Major Pharma Companies
8.1.1 Johnson & Johnson
8.1.1.1 US Sales
8.1.1.2 Advertising Spend by Channel
8.1.1.3 Global Sales and Advertising Spend
8.1.2 Pfizer
8.1.2.1 US Sales
8.1.2.2 Advertising Spend by Channel
8.1.2.3 Global Sales and Advertising Spend
8.1.3 Merck & Co.
8.1.3.1 US Sales
8.1.3.2 Advertising Spend by Channel
8.1.3.3 Global Sales and Advertising Spend
8.1.4 GlaxoSmithKline
8.1.4.1 US Sales
8.1.4.2 Advertising Spend By Channel
8.1.4.3 Global Sales and Advertising Spend
8.1.5 Eli Lilly
8.1.5.1 US Sales
8.1.5.2 Advertising Spend by Channel
8.1.5.3 Global Sales and Advertising Spend
8.1.6 Novartis
8.1.6.1 US Sales
8.1.6.2 Total Sales of Different Segments
8.1.6.3 Advertising Spend by Channel
8.1.6.4 Global Sales and Advertising Spend
8.1.7 Sanofi
8.1.7.1 US Sales
8.1.7.2 Advertising Spend on Different Segments
8.1.7.3 Global Sales and Advertising Spend
8.1.8 AstraZeneca
8.1.8.1 US Sales
8.1.8.2 Advertising Spend by Channel
8.1.8.3 Global Sales and Advertising Spend
8.1.9 Roche
8.1.9.1 US Sales
8.1.9.2 Advertising Spend on Different Segments
8.1.9.3 Global Sales and Advertising Spend
8.1.10 Bayer HealthCare
8.1.10.1 US Sales
8.1.10.2 Advertising Spend on Different Segments
8.1.10.3 Global Sales and Advertising Spend
8.1.11 Bristol- Myers Squibb
8.1.11.1 US Sales
8.1.11.2 Advertising Spend by Channel
8.1.11.3 Global Sales and Advertising Spend
9 MARKET CHALLENGES
9.1 Trust Gap between Consumers and Advertisers
9.2 Strict Rules and Regulations by FDA
9.3 Unethical Practices
9.4 Macroeconomic Scenario
9.5 Other Challenges
LIST OF FIGURES
Figure 3 1: US: Breakup of Healthcare Market
Figure 4 1: US: Healthcare Industry Digital Ad Spending (in USD Billion), 2013-2019
Figure 7 1: US: Pharmaceutical (Small Molecule Drugs) Market: Sales (in USD Billion), 2008-2015
Figure 7 2: US: Pharmaceuticals (Small Molecule Drugs): Sales Forecast (in USD Billion), 2016-2021
Figure 7 3: US: Pharmaceutical (Small Molecule Drugs) Market: Sales (in USD Billion), 2008-2015
Figure 7 4: US: Pharmaceutical (Small Molecule Drugs) Market: Sales Forecast (in USD Billion), 2016-2021
Figure 7 5: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend (in USD Billion), 2008-2015
Figure 7 6: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend Forecast (in USD Billion), 2016-2021
Figure 7 7: US: Pharmaceutical (Small Molecule Drugs) Market Advertising Spend: Breakup by Channels (in USD Billion), 2008-2015
Figure 7 8: US: Biopharmaceutical Market: Sales (in USD Billion), 2008-2015
Figure 7 9: US: Biopharmaceutical Market: Sales Forecast (in USD Billion), 2016-2021
Figure 7 10: US: Biopharmaceutical Market: Advertising Spend (in USD Billion), 2008-2015
Figure 7 11: US: Biopharmaceutical Market: Advertising Spending Forecast (in US$ Billion), 2015-2020
Figure 7 12: US: Biopharmaceutical Market: Advertising Spend: Breakup by Channels (in %), 2015
Figure 7 13: US: Biopharmaceutical Market: Advertising Spend Breakup by Different Providers (in %), 2015
Figure 7 14: US: Vaccines Market: Sales (in USD Billion), 2008-2015
Figure 7 15: US: Vaccines Market: Sales Forecast (in USD Billion), 2016-2021
Figure 7 16: US: Vaccines Market: Advertising Spend (in USD Billion), 2008-2015
Figure 7 17: US: Vaccines Market: Advertising Spend (in USD Billion), 2016-2021
Figure 7 18: US: OTC Drugs Market: Sales (in USD Billion), 2008-2015
Figure 7 19: US: OTC Drugs Market: Sales Forecast (in USD Billion), 2016-2021
Figure 7 20: US: OTC Drugs Market: Advertising Spend (in USD Billion), 2008-2015
Figure 7 21: US: OTC Drugs Market: Advertising Spend Forecast (in USD Billion), 2016-2021
Figure 7 22: US: OTC Drugs Market: Advertising Spend: Breakup by Channels (in %), 2015
Figure 8 1: US: Advertising Spend by Top Companies Breakup (in %), 2015
Figure 8 2: US: Pharmaceutical Marketing: Expenditure Breakup by Type (in %), 2015
Figure 8 3: Johnson & Johnson: US and Rest of the World Sales (in USD Billion), 2013-2015
Figure 8 4: Johnson & Johnson: Advertising Spend: Breakup by Different Channels (in %), 2015
Figure 8 5: Johnson & Johnson: Global Sales and Advertising Spend (in USD Billion), 2013-2015
Figure 8 6: Pfizer: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 7: Pfizer: Advertising Spend: Breakup by Different Channels in USA (in %), 2012
Figure 8 8: Pfizer: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 9: Merck & Co: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 10: Merck & Co: Advertising Spend: Breakup by Different Channels (in %), 2015
Figure 8 11: Merck & Co: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 12: GSK: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 13: GSK: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 8 14: GSK: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 15: Eli Lilly: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 16: Eli Lilly: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 8 17: Eli Lilly: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 18: Novartis: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 19: Novartis: Advertising Spend on Different Channels (in %), 2014
Figure 8 20: Novartis: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 21: Sanofi: US and Rest of the World sales (in USD Million), 2013-2015
Figure 8 22: Sanofi: Breakup of Spending on Different Products (in %), 2015
Figure 8 23: Sanofi: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 24: AstraZeneca: US and Rest of the World sales (in USD Million), 2013-2015
Figure 8 25: AstraZeneca: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 8 26: AstraZeneca: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 27: Roche: US and Rest of the World sales (in USD Million), 2013-2015
Figure 8 28: Roche: Breakup of Spending on Different Divisions (in %), 2014
Figure 8 29: Roche: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 30: Bayer Healthcare: US and Rest of the World sales (in USD Million), 2013-2015
Figure 8 31: Bayer & Healthcare: Breakup of Spending on Different Channels (in %), 2015
Figure 8 32: Bayer Healthcare: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 33: Bristol-Myers Squibb: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 34: Bristol-Myers Squibb: Breakup of Spending on Different Channels (in %), 2014
Figure 8 35: Bristol-Myers Squibb: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 3 1: US: Breakup of Healthcare Market
Figure 4 1: US: Healthcare Industry Digital Ad Spending (in USD Billion), 2013-2019
Figure 7 1: US: Pharmaceutical (Small Molecule Drugs) Market: Sales (in USD Billion), 2008-2015
Figure 7 2: US: Pharmaceuticals (Small Molecule Drugs): Sales Forecast (in USD Billion), 2016-2021
Figure 7 3: US: Pharmaceutical (Small Molecule Drugs) Market: Sales (in USD Billion), 2008-2015
Figure 7 4: US: Pharmaceutical (Small Molecule Drugs) Market: Sales Forecast (in USD Billion), 2016-2021
Figure 7 5: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend (in USD Billion), 2008-2015
Figure 7 6: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend Forecast (in USD Billion), 2016-2021
Figure 7 7: US: Pharmaceutical (Small Molecule Drugs) Market Advertising Spend: Breakup by Channels (in USD Billion), 2008-2015
Figure 7 8: US: Biopharmaceutical Market: Sales (in USD Billion), 2008-2015
Figure 7 9: US: Biopharmaceutical Market: Sales Forecast (in USD Billion), 2016-2021
Figure 7 10: US: Biopharmaceutical Market: Advertising Spend (in USD Billion), 2008-2015
Figure 7 11: US: Biopharmaceutical Market: Advertising Spending Forecast (in US$ Billion), 2015-2020
Figure 7 12: US: Biopharmaceutical Market: Advertising Spend: Breakup by Channels (in %), 2015
Figure 7 13: US: Biopharmaceutical Market: Advertising Spend Breakup by Different Providers (in %), 2015
Figure 7 14: US: Vaccines Market: Sales (in USD Billion), 2008-2015
Figure 7 15: US: Vaccines Market: Sales Forecast (in USD Billion), 2016-2021
Figure 7 16: US: Vaccines Market: Advertising Spend (in USD Billion), 2008-2015
Figure 7 17: US: Vaccines Market: Advertising Spend (in USD Billion), 2016-2021
Figure 7 18: US: OTC Drugs Market: Sales (in USD Billion), 2008-2015
Figure 7 19: US: OTC Drugs Market: Sales Forecast (in USD Billion), 2016-2021
Figure 7 20: US: OTC Drugs Market: Advertising Spend (in USD Billion), 2008-2015
Figure 7 21: US: OTC Drugs Market: Advertising Spend Forecast (in USD Billion), 2016-2021
Figure 7 22: US: OTC Drugs Market: Advertising Spend: Breakup by Channels (in %), 2015
Figure 8 1: US: Advertising Spend by Top Companies Breakup (in %), 2015
Figure 8 2: US: Pharmaceutical Marketing: Expenditure Breakup by Type (in %), 2015
Figure 8 3: Johnson & Johnson: US and Rest of the World Sales (in USD Billion), 2013-2015
Figure 8 4: Johnson & Johnson: Advertising Spend: Breakup by Different Channels (in %), 2015
Figure 8 5: Johnson & Johnson: Global Sales and Advertising Spend (in USD Billion), 2013-2015
Figure 8 6: Pfizer: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 7: Pfizer: Advertising Spend: Breakup by Different Channels in USA (in %), 2012
Figure 8 8: Pfizer: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 9: Merck & Co: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 10: Merck & Co: Advertising Spend: Breakup by Different Channels (in %), 2015
Figure 8 11: Merck & Co: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 12: GSK: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 13: GSK: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 8 14: GSK: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 15: Eli Lilly: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 16: Eli Lilly: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 8 17: Eli Lilly: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 18: Novartis: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 19: Novartis: Advertising Spend on Different Channels (in %), 2014
Figure 8 20: Novartis: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 21: Sanofi: US and Rest of the World sales (in USD Million), 2013-2015
Figure 8 22: Sanofi: Breakup of Spending on Different Products (in %), 2015
Figure 8 23: Sanofi: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 24: AstraZeneca: US and Rest of the World sales (in USD Million), 2013-2015
Figure 8 25: AstraZeneca: Advertising Spend: Breakup by Different Channels in the US (in %), 2012
Figure 8 26: AstraZeneca: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 27: Roche: US and Rest of the World sales (in USD Million), 2013-2015
Figure 8 28: Roche: Breakup of Spending on Different Divisions (in %), 2014
Figure 8 29: Roche: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 30: Bayer Healthcare: US and Rest of the World sales (in USD Million), 2013-2015
Figure 8 31: Bayer & Healthcare: Breakup of Spending on Different Channels (in %), 2015
Figure 8 32: Bayer Healthcare: Global Sales and Advertising Spend (in USD Million), 2013-2015
Figure 8 33: Bristol-Myers Squibb: US and Rest of the World Sales (in USD Million), 2013-2015
Figure 8 34: Bristol-Myers Squibb: Breakup of Spending on Different Channels (in %), 2014
Figure 8 35: Bristol-Myers Squibb: Global Sales and Advertising Spend (in USD Million), 2013-2015
LIST OF TABLES
Table 7 1: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend by Key Players, 2015
Table 7 2: US: Biopharmaceutical Market: Advertising Spend by Key Players, 2015
Table 7 3: US: Vaccines Market: Advertising Spend by Key Players, 2015
Table 7 4: US: OTC Drugs Market: Advertising Spend by Key Players, 2015
Table 8 1: US: Advertising Spend by Major Players, (in USD Million), 2015
Table 8 2: Pfizer: Advertising Spend on Different Channels (in USD Million), 2012
Table 8 3: Merck & Co: Advertising Spend on Different Channels (in USD Million), 2015
Table 8 4: GSK: Advertising Spend on Different Channels (in USD Million), 2012
Table 8 5: Eli Lilly: Advertising Spend on Different Channels (in USD Million), 2012
Table 8 6: Novartis: Total Sales of Different Segments (in USD Million), 2013-2015
Table 8 7: Sanofi: Advertising Spend on Different Products (in USD Million), 2015
Table 8 8: AstraZeneca: Advertising Spend on Different Channels in the US (in USD Million), 2012
Table 8 9: Roche: Total Spending on Different Divisions (in USD Million), 2014
Table 7 1: US: Pharmaceutical (Small Molecule Drugs) Market: Advertising Spend by Key Players, 2015
Table 7 2: US: Biopharmaceutical Market: Advertising Spend by Key Players, 2015
Table 7 3: US: Vaccines Market: Advertising Spend by Key Players, 2015
Table 7 4: US: OTC Drugs Market: Advertising Spend by Key Players, 2015
Table 8 1: US: Advertising Spend by Major Players, (in USD Million), 2015
Table 8 2: Pfizer: Advertising Spend on Different Channels (in USD Million), 2012
Table 8 3: Merck & Co: Advertising Spend on Different Channels (in USD Million), 2015
Table 8 4: GSK: Advertising Spend on Different Channels (in USD Million), 2012
Table 8 5: Eli Lilly: Advertising Spend on Different Channels (in USD Million), 2012
Table 8 6: Novartis: Total Sales of Different Segments (in USD Million), 2013-2015
Table 8 7: Sanofi: Advertising Spend on Different Products (in USD Million), 2015
Table 8 8: AstraZeneca: Advertising Spend on Different Channels in the US (in USD Million), 2012
Table 8 9: Roche: Total Spending on Different Divisions (in USD Million), 2014
